Safety of etomidate bolus administration in patients with septic shock

Authors: Reviewed by: Rob Green, Sean K. Gorman

Published: March 01, 2011 | Views: 1

a a

Clinical questions

In critically ill patients with septic shock, does exposure to bolus administration of etomidate increase the risk of inadequate response to corticotropin and mortality compared to no exposure?

In critically ill patients with septic shock who are exposed to bolus administration of etomidate, does hydrocortisone reduce the risk of death compared to placebo?

Article chosen

Cuthbertson BH, Sprung CL, Annane D, et al. The effects of etomidate on adrenal responsiveness and mortality in patients with septic shock. Intensive Care Med 2009;35:1868-76.

Study objective

The authors sought to test the hypotheses that bolus doses of etomidate results in an increased proportion of nonresponders to corticotropin and an increase in mortality and that hydrocortisone treatment decreases mortality in patients receiving etomidate.

To Access This Content Please Select One of the Following Options:

Login

Login to an existing account.

Subscribe to this title

Get unlimited online access to this article and all other articles in this title 24/7 for one year.

Claim access now

For current subscribers with Society Membership or Account Number.

  1. Zed PJ, Abu-Laban RB, Harrison DW. Intubating conditions and hemodynamic effects of etomidate for rapid sequence intubation in the emergency department: an observational cohort study. Acad Emerg Med 2006;13:378-83, doi:10.1111/j.1553-2712.2006.tb00313.x.
  2. Bergen JM, Smith DC. A review of etomidate for rapid sequence intubation in the emergency department. J Emerg Med 1997;15:221-30, doi:10.1016/S0736-4679(96)00350-2.
  3. Reynolds SF, Heffner J. Airway management of the critically ill patient: rapid-sequence intubation. Chest 2005;127:1397-412, doi:10.1378/chest.127.4.1397.
  4. Jackson WL. Should we use etomidate as an induction agent for endotracheal intubation in patients with septic shock?. Chest 2005;127:1031-8, doi:10.1378/chest.127.3.1031.
  5. Allolio B, Dorr H, Stuttmann R, et al. Effect of a single-bolus of etomidate upon eight major corticosteroid hormones and plasma ACTH. Clin Endocrinol 1985;22:281-6, doi:10.1111/j.1365-2265.1985.tb03241.x.
  6. Marik PE, Pastores SM, Annane D, et al. Recommendations for the diagnosis and management of corticosteroid insufficiency in critically ill adult patients: consensus statements from an international task force by the American College of Critical Care Medicine. Crit Care Med 2008;36:1937-49, doi:10.1097/CCM.0b013e31817603ba.
  7. Annane D, Sebille V, Troche G, et al. A 3-level prognostic classification in septic shock based on cortisol levels and cortisol response to corticotropin. JAMA 2000;283:1038-45.
  8. Annane D, Sebille V, Charpentier C, et al. Effect of treatment with low doses of hydrocortisone and fludrocortisone on mortality in patients with septic shock. JAMA 2002;288:862-71, doi:10.1001/jama.288.7.862.
  9. Sprung CL, Annane D, Keh D, et al. Hydrocortisone therapy for patients with septic shock. N Engl J Med 2008;358:111-24, doi:10.1056/NEJMoa071366.
  10. Delinger RP, Levy MM, Carlet JM, et al. Surviving Sepsis Campaign: international guidelines for management of severe sepsis and septic shock: 2008. Crit Care Med 2008;36:296-327, doi:10.1097/01.CCM.0000298158.12101.41.
  11. Green RS, Djogovic D, Gray S, et al. Canadian Association of Emergency Physicians Sepsis Guidelines: the optimal management of severe sepsis in Canadian emergency departments. CJEM 2008;10:443-59.
  12. Jabre P, Combes X, Lapostolle F, et al. Etomidate versus ketamine for rapid sequence intubation in acutely ill patients: a multicentre randomised controlled trial. Lancet 2009;374:293-300, doi:10.1016/S0140-6736(09)60949-1.
  13. Cuthbertson BH, Sprung CL, Annane D, et al. The effects of etomidate on adrenal responsiveness and mortality in patients with septic shock. Intensive Care Med 2009;35:1868-76, doi:10.1007/s00134-009-1603-4.
  14. Oglesby AJ. Should etomidate be the induction agent of choice for rapid sequence intubation in the emergency department?. Emerg Med J 2004;21:655-9, doi:10.1136/emj.2003.009043.
  15. Franklin C, Samuel J, Hu TC. Life-threatening hypotension associated with emergency intubation and the initiation of mechanical ventilation. Am J Emerg Med 1994;12:425-8, doi:10.1016/0735-6757(94)90053-1.
  16. Sivilotti ML, Ducharme J. Randomized, double-blind study on sedatives and hemodynamics during rapid-sequence intubation in the emergency department: the SHRED study. Ann Emerg Med 1998;31:313-24, doi:10.1016/S0196-0644(98)70341-5.
  17. Mort TC. Complications of emergency tracheal intubation: hemodynamic alterations—part I. J Intensive Care Med 2007;22:157-65, doi:10.1177/0885066607299525.
  18. Marchick MR, Kline JA, Jones AE. The significance of non-sustained hypotension in emergency department patients with sepsis. Intensive Care Med 2009;35:1261-4, doi:10.1007/s00134-009-1448-x.
  19. Katz MH. Multivariable analysis: a practical guide for clinicians. Cambridge (UK): Cambridge University Press; 1999.